Scandinavian Biopharma announces great progress in the development of ETVAX® as well as a strong organic growth for the distribution business
Scandinavian Biopharma can look back on a very successful 2018! The company was granted 7,4 million Euro from the European and Developing Countries Clinical Trials Partnership (EDCTP) for testing the protective efficacy of the ETEC vaccine candidate ETVAX® in children below five years of age in Low- and Middle-Income Countries. The distribution business achieved a […]